Neurologics is a health care startup that focuses on optimizing brain performance for individuals dealing with various brain-related conditions. The company utilizes innovative technology and medical science to assess and optimize brain function, offering personalized, non-invasive, drug-free programs. Neurologics has gained recognition for its FDA-registered assessment and optimization technology, attracting attention from Olympians, professional athletes, and renowned scientists. Recognized by MIT as a top innovator in behavioral neuroscience, the company has positively impacted over 20,000 clients. Neurologics prides itself on its tailored approach, providing services either at their assessment center in Newport Beach, CA or at the client's location. The startup is committed to enhancing brain function for individuals with conditions such as traumatic brain injury, cognitive decline, dementia, addiction, ADHD, and learning differences, as well as those striving for peak performance. With a history of proven results and a high level of customization, Neurologics aims to help individuals achieve peak brain performance. For venture capital firms looking to invest in innovative health care solutions, Neurologics presents an intriguing opportunity in the field of brain optimization.
There is no investment information
No recent news or press coverage available for Neurologics.